CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Open-market sale President/CEO and Board Chair sold 10,415 shares at $30.60 ($318,699)
- 4 Open-market sale Chief Human Resources Officer sold 4,314 shares at $30.60 ($132,008)
- 4 Open-market sale Chief Operating Officer sold 4,879 shares at $30.60 ($149,297)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $20.22 ($161,760)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,252 shares at $20.00 ($45,040)
- 4 Planned sale President/CEO and Board Chair sold 40,000 shares at an average $20.27 ($810,623)
- 4 Open-market buy Director bought 1,000 shares at $18.96 ($18,960)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Open-market sale Chief Human Resources Officer sold 8,355 shares at $16.31 ($136,270)
- 4 Open-market sale General Counsel sold 8,356 shares at $16.31 ($136,286)
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at an average $18.37 ($146,933)
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $13.24 ($105,920)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 1,604 shares at $18.00 ($28,872)
Page 7 of 17 · 330 filings